Guardant Health Inc./OS/Put [130]/JPMD

Product class

Warrant - Classic

Last exchange day

16/10/2026

Performance (1M)

51.31%

Basis price

130.0000 [USD]

Cap

- []

Leverage

9.04

Delta

-0.29

Agio p.a. in %

24.51 %

Implicit volatility

98.61 %

Guardant Health Inc. ISIN: US40131M1099
131.78 / 133.10 | 0.54 (0.411%)Bid/Ask| Change

Facts & figures

Price data

TRADE PLATFORMBörse Stuttgart (XSTU)
LAST PRICE0.96 G0 Units
PRICE DETERMINATION TIME07/24/2026 / 01:26:09 PM
DAILY VOLUME (UNITS)0
DAILY HIGH / LOW0.960.96
PREV. DAY'S PRICE0.93 (07/23)
CHANGE DAY BEFORE
+0.03
3.23 %
52 WEEK HIGH / LOW (-) (-)

Indicators

TIME OF CALCULATION
14:59:26 PM (07/24/2026)
AGIO P.A. IN %
24.51 %
LEVERAGE
9.04
DELTA
-0.29
IMPLICIT VOLATILITY
98.61 %
OMEGA
2.59
THETA
-0.86
VEGA
0.02

Master Data

WKN
JY1W8L
ISIN
DE000JY1W8L8
SYMBOL
-
EXCHANGE SEGMENT
Freiverkehr
TYPE OF FINANCIAL INSTRUMENT
Leverage Product
PRODUCT CLASS
Warrant - Classic
PRODUCT NAME
Optionsschein auf Guardant Health Inc.
ISSUER
J.P. Morgan SE
TRADING SEGMENT
EUWAX
OPTION TYPE
put
UNDERLYING
GUARDANT HEALTH INC USD0.00001
BASIS PRICE
130.0000 [USD]
CAP
- []
KNOCKIN LEVEL
- [-]
RANGE
- - -
MULTIPLIER
0.10
EXERCISE TYPE
American
TRADING CURRENCY
Euro
NOMINAL CURRENCY
EUR
SETTLEMENT CURRENCY
Euro
SMALLEST TRADABLE UNIT
1.00
MINIMUM QUOTATION EUR
3,000.00
MINIMUM QUOTATION UNITS
10,000.00
LAST VALUATION DAY
16/10/2026
PAYMENT DATE
23/10/2026
FIRST EXCHANGE DAY
12/06/2026
LAST EXCHANGE DAY
16/10/2026
TRADING HOURS
08:00:00 AM - 10:00:00 PM
QUOTATION
fortlaufende Auktion
ISSUE VOLUME
30,000,000
QUANTO
No

Underlying

WKNA2N5RY
ISIN
US40131M1099
SYMBOL
5GH
NOMINAL CURRENCY
Euro
TYPE OF UNDERLYING
Equity
COUNTRY OF THE HOME STOCK EXCHANGE
Germany

Issuer

NAME
J.P. Morgan SE
ADDRESS
J.P. Morgan SE Taunustor 1 (Taunusturm) 60310 Frankfurt am Main Deutschland
EMAIL ADDRESS
kontakt.zertifikate@jpmorgan.com
SERVICE PHONE NUMBER
069 71240
URLhttps://jpmorgan-zertifikate.de
DOCUMENTSPRIIP / KID (english)PDF icon

Product Description

This (put) warrant is linked to Guardant Health Inc., the underlying instrument, and has a term ending on October 23, 2026. This is a leveraged product, where the investor participates disproportionately in the positive and negative performance of the underlying. The investor has the right to exercise throughout the term of the warrant. Upon exercise, the redemption amount is calculated as the difference between the strike price and the price of the underlying, adjusted for the multiplier of 0.10. Exercise occurs automatically at the end of the term. If, at that point in time, the price of the underlying is above the strike price, the product will expire worthless.